Back to search

University of Leeds

Novel Target Discovery and Validation in Renal Cell Carcinoma

Abstract

dc:description.abstract

Renal cell carcinoma (RCC) is the 7th most common cancer in the UK. Almost one third of patients will have locally advanced or metastatic disease at presentation and a similar proportion will relapse despite undergoing surgery with a curative intent. More effective treatments are now available, although resistance is typically observed within months of starting treatment and median survival remains in the order of two years, highlighting the need for continued progress. The aim of this work was the discovery and further investigation of novel therapeutic targets in ccRCC through proteomic approaches. Two potential emerging targets were further investigated in ccRCC. Spleen tyrosine kinase (SYK) was identified to be alternatively spliced in ccRCC compared to normal tissue. SYK inhibition with R406 caused cell death at concentrations >1 μM. Transient Receptor Potential Canonical (TRPC) channels 1, 4 and 5 expression was variable at an mRNA level in primary ccRCC and normal kidney tissue but the lack of antibodies to accurately detect the TRPC proteins using Western blot limited detection at a protein level. The activation and inhibition of these channels in-vitro was explored in the A498 RCC cell line. A comprehensive proteomic analysis of ccRCC tissue compared with normal kidney tissue, selected on the basis of underlying genomic changes was undertaken. Integration of the data led to the identification of a number of potential novel therapeutic targets. Cyclooxygenase-1 (COX-1) and proteasome subunit type beta-9 (PSMB9), were taken forward and their upregulation in ccRCC at a protein level were demonstrated. Inhibition of COX-q was shown to cause RCC cell line death. The genetics of RCC at a descriptive level is comprehensive, but has not yet led to advances in treatment options. This work has demonstrated a valid approach to the integration of genomic and proteomic data that may be adopted in future studies.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Trainor, Sebastian
Advisors dc:contributor.advisor
  • Vasudev, Naveen
  • Banks, Roz
  • Beech, David
  • Selby, Peter

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.773976

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Trainor, Sebastian. Novel Target Discovery and Validation in Renal Cell Carcinoma. doctoral thesis, University of Leeds, 2018.